Search for stocks /

Shree Rama Multi-Tech Ltd: 40% ROE, 0% Dividend – The Nirma Tube That Cleansed Its Balance Sheet


1. At a Glance

Shree Rama Multi-Tech Ltd (SRMTL), once a debt-burdened packaging struggler, is now the Nirma Group’s shiny laminated tube specialist. With ₹220 Cr sales, ₹54.5 Cr PAT, ROE of 40%, and a market cap of ₹674 Cr, it’s suddenly looking like the overachiever cousin who cleared debt and started flexing abs. The catch? Stock trades at 4.4x book value, but still refuses to share even 1 paisa in dividends. Investors: “Return kab milega?” Company: “Sir, goodwill samjho.”


2. Introduction

Founded in 1987, SRMTL is a packaging company now majority-owned (61.6%) by Nirma group. Its bread-and-butter business is laminated tubes and laminates, the kind you see in Colgate toothpaste, pharma gels, and cosmetic creams.

SRMTL’s journey has been more filmy than financial. Once it had a Mauritius subsidiary (RIP – now defunct), a messy debt pile, and even issued preference shares at 15% coupon just two years ago. But then, enter Nirma Group with their detergent-style turnaround — cleaned up the books with a rights issue, brought discipline, and reduced borrowings from ₹161 Cr (2014) to just ₹38.8 Cr (FY25).

Today, the company boasts a respectable current ratio of 2.4, strong margins (OPM 16.7%), and impressive profit growth of 346% TTM. The only thing missing? A party for minority shareholders.


3. Business Model – WTF Do They Even Do?

SRMTL is basically the tube wala of the Nirma family. Their main products:

  • Multilayer Tubes: Toothpaste, cosmetics, pharma creams, food pastes. (Capacity: 9,514 lakh tubes annually).
  • Tube Laminates: High-performance laminates, especially for pharma.
  • Flexible Laminates: Carry packs, sachets, industrial wrappers.

User Industries: Oral care (Colgate, Dabur types), personal care (shampoos, creams), pharma (ointment tubes), food packaging (sauces, gels).

Client Base: 150 clients in India & abroad, but top 10 = 60–65% of revenues. Dependency? Yes. Diversification? Not much.

Revenue Split (FY23): India 75%, Europe 8%, Asia 13%, Africa 3%.

Basically, wherever you squeeze a tube of gel, there’s a chance SRMTL made it.


4. Financials Overview

MetricQ1 FY26Q1 FY25Q4 FY25YoY %QoQ %
Revenue₹55.4 Cr₹42.9 Cr₹59.2 Cr+28.8%-6.4%
EBITDA₹11.1 Cr₹5.3 Cr₹10.8 Cr+109%+3%
PAT₹7.35 Cr₹4.20 Cr₹36.6 Cr*
Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!